ImmuCell Stock

ImmuCell Employees 2024

ImmuCell Employees

54

Ticker

ICCC

ISIN

US4525253062

WKN

885825

In 2024, ImmuCell employed 54 people, a 0% change from the 54 number of employees in the previous year.

ImmuCell Aktienanalyse

What does ImmuCell do?

ImmuCell Corp is an American company that specializes in the development and marketing of veterinary products for the ruminant industry. It was originally founded in the late 1970s under the name PrioGene and initially focused on the development of diagnostics for tuberculosis and brucellosis in cattle. In the 1990s, the company changed its name to ImmuCell and shifted its focus to the development of products to support animal health. ImmuCell's business model is centered around the development, manufacturing, and sale of products to improve animal health. They offer a wide range of veterinary products, including immunoassays, vaccines, antibiotics, and complementary feeds. The company aims to improve animal health with minimal impact on the environment and works closely with veterinarians and industry experts. They have divisions dedicated to diagnostics, vaccines, and antibiotics, and their products can help identify and prevent diseases in livestock. Notable products include the LBC mastitis diagnostic and the Immu-PRIME spray for preventing umbilical infections in newborn calves. ImmuCell has established itself as a leading innovator in the animal health industry and has conducted clinical studies on the efficacy of their HO-VAX product. In conclusion, ImmuCell focuses on developing and marketing products to support animal health, with a commitment to improving the well-being of livestock. ImmuCell ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Employees Details

Examining ImmuCell's Employee Base

ImmuCell's employees are a pivotal aspect of its operations, driving innovation, productivity, and growth. The size and composition of the workforce offer insights into the company's scale, diversity, and investment in human capital. Analyzing employee trends and data is essential for understanding ImmuCell's operational capacity and future potential.

Year-to-Year Comparison

Assessing ImmuCell's employee numbers year-over-year helps in identifying growth patterns, expansions, or contractions. An increasing employee count can indicate scaling operations and investment in talent, while a decrease may signal efficiency improvements, automation, or business challenges.

Impact on Investments

ImmuCell's employee data impacts investment decisions by shedding light on the company’s operational efficiency, innovation capability, and sustainability. Investors assess workforce data to gauge the firm's potential to execute strategies, innovate, and adapt to market changes effectively.

Interpreting Employee Trends

Fluctuations in ImmuCell’s employee numbers indicate changes in business strategy, operational demands, and market dynamics. Investors and analysts scrutinize these trends to evaluate the company’s strategic positioning, adaptability, and potential for sustainable growth.

Frequently Asked Questions about ImmuCell stock

How many employees does ImmuCell have this year?

ImmuCell has 54 undefined employees this year.

How many employees did ImmuCell have compared to the previous year?

Compared to the previous year, ImmuCell had 0% more employees.

What impact did the number of employees have on the company ImmuCell?

The number of employees has a direct impact on the efficiency and productivity of ImmuCell. A higher number of employees can indicate that the company is growing and has more resources to achieve its goals, while a lower number of employees may suggest that the company is saving costs or facing difficulties in recruiting new employees.

What impact did the number of employees have on investors of ImmuCell?

The number of employees can also have an impact on investors of ImmuCell, as it can be an indicator of the company's growth and financial health. A higher number of employees can promise investors, while a lower number of employees may raise concerns.

How does an increase in equity capital of ImmuCell affect the company?

An increase in equity of ImmuCell can improve the financial strength of the company and increase its ability to make future investments and fulfill obligations.

How does a reduction in ImmuCell's equity affect the company?

A reduction in equity of ImmuCell can impair its financial stability and decrease its ability to fulfill future investments and obligations.

What are some factors that influence the equity of ImmuCell?

Some factors that can influence the equity of ImmuCell include, among others, revenue development, profit and loss statement, dividend payments, and investments.

Why is the equity of ImmuCell so important for investors?

The equity of ImmuCell is important for investors as it is an indicator of the company's financial stability and provides investors with information on the amount of financial backing the company has in terms of obligations and future investments.

How does the number of employees at ImmuCell influence the company?

The number of employees at ImmuCell can directly impact the growth and performance of the company. A higher number of employees can lead to increased capacity and productivity, while a lower number of employees may result in reduced efficiency and limitations.

How has the number of employees at ImmuCell evolved in recent years?

In recent years, the number of employees at ImmuCell has changed by 0.

How many employees does ImmuCell currently have?

ImmuCell currently has 54 undefined employees.

Why is the number of employees important for investors of ImmuCell?

The number of employees is important for investors of ImmuCell as it is an indicator of the growth potential and performance of the company. It also provides information on how the company is able to manage and recruit its workforce.

What strategic measures can ImmuCell take to change the number of employees?

To change the number of employees, ImmuCell can take various measures such as adjusting compensation packages, improving working conditions, conducting recruitment campaigns, and promoting a positive corporate culture. It is important for the company to conduct a thorough assessment of its situation to determine the best strategic actions to change its number of employees.

How much dividend does ImmuCell pay?

Over the past 12 months, ImmuCell paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, ImmuCell is expected to pay a dividend of 0 USD.

What is the dividend yield of ImmuCell?

The current dividend yield of ImmuCell is .

When does ImmuCell pay dividends?

ImmuCell pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of ImmuCell?

ImmuCell paid dividends every year for the past 0 years.

What is the dividend of ImmuCell?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is ImmuCell located?

ImmuCell is assigned to the 'Health' sector.

Wann musste ich die Aktien von ImmuCell kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of ImmuCell from 7/11/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 7/11/2024.

When did ImmuCell pay the last dividend?

The last dividend was paid out on 7/11/2024.

What was the dividend of ImmuCell in the year 2023?

In the year 2023, ImmuCell distributed 0 USD as dividends.

In which currency does ImmuCell pay out the dividend?

The dividends of ImmuCell are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von ImmuCell

Our stock analysis for ImmuCell Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of ImmuCell Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.